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Systematic optimization of human 
pluripotent stem cells media using 
Design of Experiments
Paulo A. Marinho, Thanathom Chailangkarn & Alysson R. Muotri
Human pluripotent stem cells (hPSC) are used to study the early stages of human development in 
vitro and, increasingly due to somatic cell reprogramming, cellular and molecular mechanisms of 
disease. Cell culture medium is a critical factor for hPSC to maintain pluripotency and self-renewal. 
Numerous defined culture media have been empirically developed but never systematically optimized 
for culturing hPSC. We applied design of experiments (DOE), a powerful statistical tool, to improve 
the medium formulation for hPSC. Using pluripotency and cell growth as read-outs, we determined 
the optimal concentration of both basic fibroblast growth factor (bFGF) and neuregulin−1 beta 1 
(NRG1β1). The resulting formulation, named iDEAL, improved the maintenance and passage of hPSC 
in both normal and stressful conditions, and affected trimethylated histone 3 lysine 27 (H3K27me3) 
epigenetic status after genetic reprogramming. It also enhances efficient hPSC plating as single cells. 
Altogether, iDEAL potentially allows scalable and controllable hPSC culture routine in translational 
research. Our DOE strategy could also be applied to hPSC differentiation protocols, which often 
require numerous and complex cell culture media.
Despite the numerous and rapid advances in hPSC technology over the past decade1–5, culture conditions 
still rely on empirically formulated media. As an example, the most widely used commercially available 
feeder free culture medium for hPSCs, mTeSR1, has raised concerns about the accumulation of spon-
taneous differentiation in the culture, requiring labor-intensive cleaning procedures and unavoidably 
daily routine of media change6 with substantially high cost for culture maintenance. As a consequence, 
the hPSC field continues to use suboptimal culture conditions that could lead to experimental variation 
or even mask important observations. One well-known example is the inconsistency of X-chromosome 
inactivation status in hPSC from different labs. Problems associated with empirically formulated media 
could be explained by the lack of well-designed optimization steps while evaluating the interactions 
between manifold components.
DOE is a mathematical technique that can be used to determine the optimal set of conditions across 
many different changeable parameters7,8. One of the greatest advantages of the DOE approach is the 
capacity to reduce the number of experiments needed to identify an optimal set of conditions. For this 
reason, DOE is routinely used in several fields of study; engineers use DOE to optimize physical structure 
design9–11 and medicinal chemists use DOE to optimize drug formulation12,13. However, DOE has never 
been used to optimize hPSC culture conditions. In this work, we sought to improve hPSC culture con-
ditions by optimizing the levels of two well-established growth factors that regulate pluripotency: basic 
fibroblast growth factor (bFGF)14,15 and neuregulin-1beta 1 (NRG1β1)15.
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Results
Development of media formulation. A 2-variable rotatable central composite design (2RCCD) was 
used to generate nine conditions (Table 1) allowing us to test bFGF from 0 to 60 ng/mL and NRG1β1 
from 0 to 16 ng/mL. Each of the nine conditions was prepared in xeno-free basal medium that was 
previously optimized by our group (Supplementary Table 1) by several steps using different DOEs tech-
niques16 (Fig. 1a). Efficacy was determined by measuring self-renewal (final cell concentration achieved) 
and pluripotency (dual positive staining for OCT4 and NANOG) of human embryonic stem cells (H9) 
using unbiased flow cytometry and automated cell counter. Although there are several ways to measure 
pluripotency, we choose these parameters because they are easy quantifiable read-outs. Further confir-
mation of pluripotency using other methods was tested on our final formulation (see below). The linear, 
quadratic and synergetic effects of each factor were generated (Table 2) and statistically relevant param-
eters that characterize self-renewal and pluripotency were used to make response surfaces (Fig.  1b,c). 
The pluripotency surface predicted that the optimum condition of bFGF was 35–45 ng/mL but found no 
effect based on the concentration of NRG1β1 (Fig. 1b). The self-renewal surface predicted the optimum 
conditions were 50 ng/mL bFGF and 16 ng/mL NRG1β1 (Fig.  1c). However, a better readout could be 
expected by extrapolating the up range of NRG1β1 value. Both surfaces fit the data reasonably well 
(R2 = 0.70). The fit between the observed effects and the model were weakest in regions of low pluripo-
tency and self-renewal, which are regions of less interest (Fig. 2).
One potential shortcoming of this model is that bias might be introduced by the conditions entirely 
lacking in either bFGF or NRG1β1. To address this, a second set of experiments was performed where 
the minimum value tested for each factor was 1 ng/mL. In addition, the maximum value for NRG1β1 
was increased from 16 ng/mL to 21 ng/mL based on extrapolations from the previous model. Again, a 
2RCCD design (Table 1) was used to determine the test conditions and two readouts – pluripotency and 
self-renewal – were used to generate a second model (Table 2). In this model, maximal pluripotency was 
observed near 51 ng/mL of bFGF and 21 ng/mL of NRG1β1 (Fig. 1d). Maximal self-renewal was observed 
at 45 ng/mL of bFGF regardless of the concentration of NRG1β1 (Fig. 1e). Although self-renewal showed 
a poor correlation (R2 = 0.51), pluripotency was a better fit (R2 = 0.72). Taken together, both models sup-
port the choice of 51ng/mL of bFGF and 21 ng/mL of NRG1β1 for the formulation of an optimized 
media for self-renewal and pluripotency, which we refer to as iDEAL (Supplementary Table 2).
Conditions bFGF NRG1β1
1 −1 −1
2 −1 +1
3 +1 −1
4 +1 +1
5 −1.41 0
6 +1.41 0
7 0 −1.41
8 0 +1.41
9 0 0
Concentrations on 1st model μg/L μg/L
+1.41 60 16
+1 51.2 13.6
0 30 8
−1 8.8 2.4
−1.41 0 0
Concentrations on 2nd model μg/L μg/L
+1.41 61 21
+1 52.2 18.1
0 31 11
−1 9.8 3.9
−1.41 1 1
Table 1.  Concentration of the factors in each experimental condition evaluated for the 2 independent 
2RCCDs. Nine conditions were created in a matrix according to 2RCCD. The un-coded values of each 
number in the matrix are showed below for every model and factor.
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iDEAL improves hPSC culture maintenance. To determine whether iDEAL improves the main-
tenance of pluripotency in hPSCs, we generated 3 lines of induced pluripotent stem cells (iPSC1, iPSC2 
and iPSC3) from isolated female human fibroblasts using the methods described elsewhere17. After man-
ual isolation from mouse embryonic fibroblasts (MEFs), iPSCs were cultivated without feeder cells using 
Figure 1. A model for hPSC media optimization using design of experiments. (a) Schematics of the 
rational used on the development of a completely recombinant, xeno- and feeder-free media. Each box 
represents one independent design, varying from 2 to 12 different factors, each designed was repeated 
one to three times depending on the readout of the model (number inside the box). The area dashed in 
red represents the part of media optimization that is reported in this manuscript. The first optimization 
from this work was performed using 0 – 60 ng of bFGF/mL and 0 – 16 ng of NRG1β1/mL. The second 
optimization was performed using 1 – 61 ng of bFGF/mL and 1 – 21 ng of NRG1β1/mL. Mathematical 
models were used to analyze the results from either the dual staining of OCT4 and NANOG (b, d) or for 
final cell concentration (c, e) White dots in the graphics represent the actual conditions performed. Colors 
ranging from dark red to dark green represent the highest to the lowest value for pluripotency and self-
renewal. The dashed area in each model represents the optimum range predicted by the model to maximize 
the readout.
www.nature.com/scientificreports/
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iDEAL or mTeSR1 as culture medium and Matrigel as extracellular matrix. Number of iPSC clones and 
technical replicates for each experiment were summarized in Supplementary Table 3. Similar to mTeSR1, 
all iPSCs derived in iDEAL expressed pluripotent markers, were able to differentiate into 3 germ layers in 
vitro and in vivo (teratomas), and maintained a normal karyotype (Supplementary Fig. 1). Late passage 
karyotyping analyses were also performed in different cell lines, as shown in our published patent16. After 
7 days in culture with media changed on a daily basis, iPSCs (passage 20) derived in iDEAL or mTeSR1 
are morphologically identical (Fig. 3a, top row) and have a similar percentage of cells undergoing apop-
tosis (sub-G1 phase population) as assessed by propidium iodide staining followed by flow cytome-
try18,19 (Fig. 3b,c). Regardless of the slightly intrinsic variations of different G1, S and G2/M populations 
between lines (Supplementary Fig. 2), it is undeniable that iDEAL maintained pluripotency better than 
mTeSR1, as indicated by a significantly (P = 0.0035 for iPSC1, P = 0.0033 for iPSC2 and P < 0.0001 for 
iPSC3, two-sided unpaired Student’s t test) higher percentage of double OCT4- and NANOG-positive 
cells (Fig. 3d,e). It was notable that even when the media was changed daily, approximately 60–70% of 
the cells remained pluripotent when cultured in mTeSR1, a finding we attribute to the result of unbi-
ased passaging where differentiated cells are not removed prior to passaging (see Methods). In contrast, 
iDEAL cultures did not accumulate these differentiated cells.
The use of mTeSR1 for culturing iPSCs is both expensive and labor intensive as the cells need to be 
fed everyday due to their high metabolic activities6. To compare the two, we introduced a stressful con-
dition by not changing the media on day 5 and 6 after passaging and then determined pluripotency and 
1st 2RCCD
Self-renewal Coefficient Error t (4) p-value Min (90%) Max (90%)
Mean 4.21 0.05 89.32 0.00 4.11 4.31
bFGF (Linear) 0.28 0.04 7.49 0.00 0.20 0.36
bFGF (Quadratic) −0.10 0.04 −2.60 0.06 −0.19 −0.02
NRG1β1 (Linear) 0.14 0.04 3.64 0.02 0.06 0.22
NRG1β1 (Quadratic). 0.04 0.04 1.09 0.34 −0.04 0.13
bFGF x NRG1β1 −0.09 0.05 −1.80 0.15 −0.21 0.02
Pluripotency Coefficient Error t (4) p-value Min (90%) Max (90%)
Mean 89.18 0.61 145.94 0.00 87.88 90.48
bFGF (Linear) 2.16 0.48 4.48 0.01 1.13 3.19
bFGF (Quadratic) −3.69 0.52 −7.12 0.00 -4.79 -2.59
NRG1β1 (Linear) -0.52 0.48 -1.07 0.34 -1.55 0.51
NRG1β1 (Quadratic). 0.29 0.52 0.55 0.61 -0.82 1.39
bFGF x NRG1β1 1.08 0.68 1.57 0.19 -0.38 2.53
2nd 2RCCD
Self-renewal Coefficient Error t (4) p-value Min (90%) Max (90%)
Mean 4.90 0.13 38.76 0.00 4.63 5.17
bFGF (Linear) 0.27 0.10 2.72 0.05 0.06 0.49
bFGF (Quadratic) −0.27 0.11 −2.51 0.07 −0.50 −0.04
NRG1β1 (Linear) 0.14 0.10 1.38 0.24 −0.08 0.35
NRG1β1 (Quadratic). −0.12 0.11 −1.09 0.34 −0.35 0.11
bFGF x NRG1β1 −0.10 0.14 −0.72 0.51 −0.40 0.20
Pluripotency Coefficient Error t (4) p-value Min (90%) Max (90%)
Mean 93.78 0.41 230.59 0.00 92.91 94.65
bFGF (Linear) 0.94 0.32 2.93 0.04 0.26 1.63
bFGF (Quadratic) −1.23 0.34 −3.56 0.02 −1.96 −0.49
NRG1β1 (Linear) −0.14 0.32 −0.44 0.68 −0.83 0.54
NRG1β1 (Quadratic). 1.10 0.34 3.18 0.03 0.36 1.83
bFGF x NRG1β1 1.08 0.45 2.36 0.08 0.11 2.04
Table 2.  Effects and statistical relevance of each mathematical parameter in the 2RCCDs. The linear, 
quadratic and synergetic effects of each factor are represented on the coefficient column. The statistical 
relevance (t) and the p-value were also calculated and every parameter with a p-value < 0.1 was considered 
statistically relevant (highlighted in red). The columns “Min” and “Max” represent the margin values of each 
parameter with 90% confidence.
www.nature.com/scientificreports/
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cell death on day 7. Whereas iPSC colonies in iDEAL appeared to be morphologically normal (Fig. 3a, 
bottom left), iPSCs in mTeSR1 showed morphological alterations at the edge of colony (Fig. 3a, bottom 
right). iPSCs in iDEAL had few sub-G1 cells (Fig. 3f, left and g, black bar) and maintained expression 
of both OCT4 and NANOG (Fig. 3h, left and i, black bar). In contrast, cells cultured in mTeSR1 had a 
significantly larger population of sub-G1 cells (Fig. 3f, right and 3G, white bar, P = 0.0046 for iPSC2 and 
P = 0.0118 for iPSC3, two-sided unpaired Student’s t test) and decreased expression of both OCT4 and 
NANOG (Fig.  3h, right and i white bar, P = 0.0146 for iPSC1, P = 0.0155 for iPSC2 and P = 0.0268 for 
iPSC3, two-sided unpaired Student’s t test). These results suggest that iDEAL maintains iPSC pluripo-
tency and minimized cell death more efficiently than mTeSR1.
iDEAL facilitates single hPSC passaging. hPSC are typically passaged as small clumps and not 
as single cells in order to keep them viable and undifferentiated20,21. This practice though makes hPSC 
maintenance much more tedious and time consuming as compared to the maintenance of other cell types 
such as fibroblasts and neural progenitor cells where complete dissociation during passaging is feasible. 
We determined whether iPSCs derived in iDEAL could survive single-cell plating while maintaining 
pluripotency. When the same number of iPSCs dissociated into single cells was plated in either iDEAL 
or mTeSR1, with the addition of 10 μM Rock inhibitor (Supplementary Fig. 3a), the number of live cells 
in iDEAL 1 day later were significantly (P = 0.0007 for iPSC1, P = 0.002 for iPSC2 and P = 0.0001 for 
iPSC3, two-sided unpaired Student’s t test) higher than in mTeSR1 (Fig. 4a, top row, and b). Moreover, 
since dissociation could induce the differentiation22, we also measured the pluripotency of surviving cells. 
Although differentiated cells were clearly observed in mTeSR1 culture (Fig. 4a, bottom right) and not in 
iDEAL culture (Fig. 4a, bottom left) 7 days after plating, the percentage cells expressing both NANOG 
and OCT4 as assessed by flow cytometry was not significantly lower in mTeSR1 culture (Fig.  4c,d). 
iDEAL-derived iPSCs that were passaged as single cells for 5 passages remained highly positive for both 
NANOG and OCT4 (Supplementary Fig. 3b) and were capable of forming EBs (Supplementary Fig. 3c), 
suggesting that pluripotency of iDEAL-derived iPSCs were maintained after several single-cell passaging. 
These results indicate that iDEAL would be a better choice for iPSC single-cell passaging, as it is simpler 
and faster than traditional clump passaging.
Effect of iDEAL on X chromosome inactivation (XCI) status of iPSCs. The mechanism of reac-
tivation of X chromosomes during reprogramming is not fully understood23, limiting the potential of 
iPSCs for X-linked diseases24. It has been shown recently that the addition of recombinant leukemia 
inhibitory factor (LIF) to the hPSC culture can reactivate inactive X chromosome observed in early pas-
sage25, suggesting that media formulations can influence the status of X chromosome. In order to test the 
hypothesis that iDEAL could influence the X-inactivation status during the derivation of iPSCs, we meas-
ured the epigenetic marker trimethylated histone 3 lysine 27 (H3K27me3) in iPSCs derived in mTeSR1 or 
iDEAL. H3K27me3 marks silenced DNA including the inactive X chromosome in interphase nuclei26,27. 
This mark has been widely used to discriminate the status of X chromosomes in human pluripotent stem 
cells17,28,29. Half of the iPSC clones derived in iDEAL did not generated H3K27me3 staining foci in early 
Figure 2. Model predictability. For each experimental condition, the observed (measured) value (blue 
dot) and the value predicted by the mathematical model for (a) self-renewal and (b) pluripotency, was 
shown. The less the distance between blue dot and the line of perfect predictability (red dashed line) is, the 
more the reliability of the model for that region is. The black arrows highlight the low predictability of the 
condition with lowest performance, in both cases, the experimental condition 5 (Table 1). However, in our 
region of interest (inside solid green lines), the distance between the line of perfect predictability and the 
blue dots inside that region is small in most of the cases. This confirms that the model can predict, in the 
range analyzed, the conditions with outstanding performance.
www.nature.com/scientificreports/
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Figure 3. The optimized iDEAL medium increases pluripotency of hPSC. (a) Representative images of iPSCs passage 
20 derived in iDEAL or mTeSR1 when the media were changed daily (top), or skipped on day 5 and 6 (bottom). 
Scale bar, 200 μm. (b) Representative cell cycle profiles of iPSC assessed by flow cytometry at day 7 after passaging 
when media were changed daily. (c) Sub-G1 population (%) at day 7 after passaging when media were changed daily. 
(d) Representative expression of pluripotent markers OCT4 and NANOG assessed by flow cytometry at day 7 after 
passaging when media were changed daily. (e) iPSC population (%) with OCT4 and NANOG expression at day 7 after 
passaging when media were changed daily. (f) Representative cell cycle profiles of iPSC at day 7 after passaging when 
media were skipped on day 5 and 6. (g) Change in sub-G1 population at day 7 after passaging when media were skipped 
on day 5 and 6. For each media type, sub-G1 iPSC population (%) in skipped condition was normalized to that in daily 
condition. (h) Representative expression of OCT4 and NANOG at day 7 after passaging when media were skipped on 
day 5 and 6. (i) Change in OCT4+and NANOG+population at day 7 after passaging when media change was skipped 
on day 5 and 6. For each media type, iPSC population (%) with OCT4 and NANOG expression in skipped condition 
was normalized to that in daily condition. Black bars represent iPSC derived in iDEAL, White bars represent iPSC 
derived in mTeSR1. For (c,e,g,i), data were shown as mean ± s.e.m for each of 3 iPSC lines (one clone each). n (technical 
replicates)=3. *P < 0.05, **P < 0.01, ***P < 0.001, two-sided unpaired Student’s t test.
www.nature.com/scientificreports/
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Figure 4. The optimized iDEAL medium improves single-cell survival of hPSC. (a) Representative 
images of iPSCs passage 20 plated as single cells in iDEAL or mTeSR1 at day 1 and at day 7. Arrows point 
to differentiated cells. Scale bar, 200 μm. (b) Survival index of iPSCs at day 1 after plating calculated by 
dividing number of live cells at day 1 by number of cells plated on day 0. (c) Representative expression of 
pluripotent markers OCT4 and NANOG assessed by flow cytometry at day 7 after plating as single cells in 
each medium. (d) iPSC population (%) with OCT4 and NANOG expression at day 7 after plating as single 
cells. Black bars represent iPSC derived in iDEAL, White bars represent iPSC derived in mTeSR1. Data 
were shown as mean ± s.e.m for each of 3 iPSC lines (one clone each). n (technical replicates)=4. **P < 0.01, 
***P < 0.001, two-sided unpaired Student’s t test.
www.nature.com/scientificreports/
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passages (Fig.  5a). However, all iPSC clones derived in mTeSR1 had a very clear positive staining for 
H3K27me3 (Fig. 5b). Similar results were found for cells after >10 passages thereby ruling out the possi-
bility that iDEAL simply resulted in a delayed transitory state (Fig. 5c). The absence of H3K27me3 marks 
in late passage of iPSCs could be caused by erosion of XCI24 or by the loss of those marks even though 
the X chromosome remains inactive30. To test for these possibilities, we performed a media swap exper-
iment and found that the H3K27me3 mark could be detected after changing from iDEAL to mTeSR1 
(Fig. 5d). This suggests that the absence of H3K27me3 was not due to either erosion of XCI or the loss 
of XCI marks in inactive X chromosome. Moreover, these studies allowed us to determine if iDEAL was 
able to reset this epigenetic marker. Similar to iPSCs derived and maintained in mTeSR1 (Fig.  5e), we 
found that iPSC clones initially cultured in mTeSR1 retained H3K27me3 foci when transferred to iDEAL 
(Fig. 5f). This suggests that rather than controlling the presence of H3K27me3, iDEAL maintained the 
absence status of this marker once it was set upon reprogramming. We validated these observations by 
performing fluorescent in situ hybridization (FISH) using the XIST RNA expression, another marker 
for inactive X chromosomes31. Whereas XIST RNA was clearly expressed in fibroblasts before repro-
gramming (Fig. 5g), positive control (Fig. 5h) and fibroblast-derived iPSCs in mTeSR1 (Fig. 5j), it was 
not detected in iPSCs derived in iDEAL (Fig. 5i). This result suggests that the medium formulation can 
affect the X activation status. It is important to note that 3 out of 6 clones from one iPSC line derived in 
iDEAL showed no H3K27me3 mark for entire population, and one clone showed mixed population for 
this marker. Nonetheless, our findings, consistent with those of others, demonstrate the importance of 
culture medium on epigenetic markers involving X inactivation in female iPSCs.
Discussion
The striking advantage of DOE over other empirical methods in the optimization of multiple parameters 
is that the most optimal condition could be mathematically and statistically determined when sufficient 
conditions are tested. We introduced this strategy to pluripotent stem cell research and showed its prac-
tical application by using hPSC culture media as an example. We developed the final media for hPSC, 
iDEAL in feeder-free Matrigel based system, by optimizing the final concentration of 2 empirically estab-
lished factors; bFGF and NRG1β1. While bFGF is long known as major factor keeping pluripotent stem 
cells in undifferentiated state32,33, NRG1β1 has been proved to be another important player for less than 
10 years15. For maintaining hPSC in feeder-free system, many groups have claimed best concentration 
of bFGF at 100 ng/mL34,35 for over decades and of NRG1β1 at 10 ng/mL15. Regular methods to define 
best concentrations in hPSC field usually starts with random dictates of the concentration developed 
around the previously known values, followed by the test of each concentration34,36. The one with the 
best readouts, e.g. lowest apoptotic and highest proliferation rate, was selected and claimed as the most 
optimal concentration that should be used to maintain hPSC culture. This empirical method has two 
major drawbacks. First, the true ‘best concentration’ could possibly fall in the untested interval between 
the ones chosen by experimenters. Second, since those studies optimized the concentration of one factor 
at a time, the interaction between these factors that could affect the readouts is neglected. This is the 
Figure 5. H3K27me3 mark in iPSCs is influenced by culture media. Immunostaining profile of 
H3K27me3 (puncta) and NANOG and XIST expression on iPSCs derived in different media. Cells derived 
in iDEAL medium (a, c, d) and in mTeSR1 medium (b, e, f). Immunostaining was performed at the 
establishment of the line (A, B), passage 4, and after long-term maintenance (c, e), passage 10, with media 
swap from passages 7 to 10 (d, f). Scale bar, 100 μm. XIST RNA FISH was performed in fibroblast before 
reprogramming (g), positive control fibroblast (h), iPSC derived in iDEAL (i) and iPSC derived in mTeSR1 
(j).
www.nature.com/scientificreports/
9Scientific RepoRts | 5:09834 | DOi: 10.1038/srep09834
case for the pluripotency E8 media, while some of their discovers are extremely relevant as the toxic 
influence of the β-mercaptoethanol (BME) in albumin-free media37 as our group also demonstrated few 
years ago in a dose-dependent manner16, other hypothesis for optimizing the media are simply removing 
few components from mTeSR1 media instead of understanding their real contribution. For instance, we 
have identified that the optimum supplementation of non-essential amino acids (NEAA), glutamine and 
citric acid on a DMEM/F12 based medium could increase cell proliferation by 20-30%16. In contrast to 
mTeSR1 or iDEAL, the E8 media do not use NEAA supplementation as38,39, it was just removed without 
proper measurement of its effect the overall formulation. The same is also valid for other factors, such as 
serum derived albumin. While the concerns of inter-batch variability from serum-derived components 
is undeniable, options of recombinant proteins with insignificant batch-to-batch variation are already 
available and therefore could be used as option to improve the media in a cost-effective fashion, as it 
was done in iDEAL pre-development16. The pluripotency and number of cells from each condition tested 
were used to mathematically generate the model and find the most optimal concentration of these fac-
tors. For NRG1β1, the first optimization suggested that 12 ng/mL or higher should be used to keep both 
pluripotency and self-renewal at maximal performance. In the second optimization conducted to validate 
that the absence of these factors did not bias the model, any concentration resulted in similar percentage 
of self-renewal. However, this is not the case for pluripotency where only high concentration must be 
used to maintain high percentage of pluripotency. Hence, to satisfy both pluripotency and self-renewal 
at highest efficiency, only high range of NRG1β1 must be used in the formulation. Our results indicate 
that iDEAL could contribute to many aspects of stem cell research.
As hPSC work routine requires daily feeding, the ideal concept of weekend-free hPSC culture has 
been developed for a while. In general, since the cell density on the day after passaging (day 1) is low 
and thus the metabolic activity is not as high, the feeding could be omitted on the day after passaging. 
By adding extra media to the culture on the day passaging is done (day 0) as commercially suggested, it 
is expectedly feasible to let the cells stay in the same environment for another day (continuously omit-
ted on day 1 and day 2). In other words, weekend-free hPSC culture is possible only if the passaging is 
done on Friday. In our study, to more extreme extent, we skipped the media change on day 5 and 6 after 
passaging when the cells are almost confluent and iDEAL still maintained the level of cell death and 
pluripotency as if the cells were fed daily. We speculate that the difference in apoptosis between the two 
systems is likely due to the fact that that empirically formulated medium (mTeSR1) was not truly flexible 
to accommodate stressful conditions, limiting the range of tolerance for hPSC in this system. On the 
other hand, systematically optimized medium (iDEAL) can better buffer the cellular stress, presumably 
by inducing intrinsic epigenetic modifications in a subset of genes/pathways responsible for this flexi-
bility. Thus, we prove that iDEAL supports the weekend-free culture regardless of the day the passaging 
performed, allowing more flexible work routine.
While small amount of spontaneous differentiation in hPSC culture is expected and signifies that 
these cells are capable of differentiating into other cell types, excessive amount could be a problem as it 
could interfere with culture maintenance as well as an intended differentiation. Several published proto-
cols recommend removing differentiated cells from hPSC culture before passaging21,39–44. Such time- and 
labor-consuming step is not required when iPSCs are in iDEAL system; most likely this could be related 
to the fine optimization of growth factors known to interfere in pluripotency such as FGF-2 and NRG1β1, 
the last one absent in mediums like mTeSR1 or E8. In our study, iPSC culture in mTeSR1 accumulated 
differentiated cells over passages as shown by lower percentage of pluripotency compared to culture in 
iDEAL at the same passage number. One might argue that difference between cell lines themselves could 
presumably contribute to the level of pluripotency as well as subG1 population45. While this seems to be 
the case for mTeSR1 culture as the variation was clearly observed between iPSC lines, the discrepancy 
was greatly reduced when cells from the same subjects were in iDEAL culture condition, implying that 
iPSCs in iDEAL are in more naïve state, the ideal scenario one would like to have in hPSC culture.
Single-cell plating of hPSC has been pursuing in the field but never been efficient either because of 
low survival of hPSC after complete dissociation21 or the requirement of several extra factors added 
to culture medium46. However, our optimized medium supplemented with ROCK inhibitor only on 
day 0 overcomes these 2 obstacles. In a pilot single-cell plating experiment, we did not add ROCK 
inhibitor to the culture when plating single iPSCs. Unlike iDEAL-derived iPSCs, mTeSR1-derived iPSCs 
plated without ROCK inhibitor had a very low percentage of survival after single-cell plating and took 
unusually long time to recover, making the comparison between two media non reliable. To have suf-
ficient mTeSR1-derived iPSCs for the analysis and allow for comparison with iDEAL-derived iPSCs in 
timely fashion, we added ROCK inhibitor to both medium systems when we plated them (day 0 only). 
Although we have not looked further than survival and pluripotent marker expression of plated iPSCs 
after complete dissociation, the readouts are sufficient enough to show the vast difference between the 
cells cultured in each media. The survival of hPSC in iDEAL is doubly improved from that in mTeSR1 
while maintaining the pluripotency at the same level. This complete dissociation method combined with 
iDEAL could be adapted as routine hPSC passaging, hugely decreasing time spent carefully breaking 
down hPSC colonies and facilitating scalable and controllable culture for industrial and clinical uses 
as the passaging protocol becomes as simple as the one for routine fibroblast passaging. Moreover, this 
system could also potentially facilitate particular technique such as plasmid transfection in hPSC via 
electroporation. The more the single iPSCs survive, the greater the transfection efficiency is obtained. 
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Further analyses are needed to verify that quality of hPSCs passaged as single cells in iDEAL is similar 
to that of hPSCs passaged as clumps.
The inconsistency of XCI status in hiPSCs has been reported47. While most groups generated hiP-
SCs retaining one inactive X chromosome48–51, a few showed that inactive X chromosome in somatic 
cells is reactivated upon reprogramming17,52. Although it is unclear how reactivation of X chromosome 
upon reprogramming could be manipulated in the culture, several studies found that the derivation 
and culture conditions, such as oxygen levels53 and persistency of pluripotent factor expression54, could 
influence the status of the X chromosome. Medium composition has been shown to reactivate inactive X 
chromosome in iPSC at a few passages after reprogramming25. Using iDEAL, we were also able to derive 
iPSCs with both active X chromosomes with at least 50% efficiency although the results were based on 
only the absence of H3K27me3 and of XIST RNA expression. When studying expression of X-linked 
genes and XCI status upon differentiation, iDEAL could be an attractive tool to reactivate X chromosome 
upon reprogramming.
Conclusion
We have developed a systematically optimized hPSC media, iDEAL. By using DOE, we are able to 
manipulate and discover the most effective combination of bFGF and NRG1β1 that robustly improves 
culture condition for hPSC. DOE could also be further applied to improve numerous non-fully defined 
or non-optimal conditions in hPSC field, such as differentiation protocols to obtain specific cell types 
that have low differentiation efficiency or reprogramming conditions. The whole optimization of iDEAL 
formulation has several advantages over empirically-formulated media. By maintaining a higher per-
centage of pluripotent cells, the use of iDEAL could decrease the vast amount of time spent removing 
unwanted differentiated cells typically present in iPSC cultures. The use of iDEAL also results in cultures 
with increased viability, even if the media is not changed for two days. Moreover, iDEAL improves the 
survival of iPSCs when plated as single cells, which could be very useful for routine passaging and several 
assays including transfection and drug screening, such as for genome editing. Finally, our data strongly 
suggest that hPSC media can influence epigenetic markers and X inactivation. Further improvements 
on our formulation will maximize the use of iDEAL in assays requiring consistency of X-chromosome 
inactivation status. More broadly, these findings show that a mathematical modeling approach can be 
used to solve sophisticated biological problems by systematic optimization of numerous different factors. 
Our data strongly support the need of systematical optimization of hPSC culture conditions and similar 
strategy can be used for hPSC differentiation protocols.
Materials and Methods
Mathematical Modeling and Statistical Analysis. The methodology for the medium optimization 
using H9 cells consisted of a 2-variable rotatable central composite design (2RCCD). Mainly, two read-
outs were used in order to evaluate self-renewal and pluripotency of H9 cells. The first one, self-renewal, 
was obtained through the automated counting of the cell concentration after at least 6 days of culture. 
Pluripotency was defined as the percentage of the population double-stained for NANOG and OCT4 
at the end of the culture. The software Statistica 7.0 (StatSoft, USA) was used in order to generate the 
matrixes which contained the specification of each medium condition formulation, accordingly to the 
variation created for every supplement for the concentration range set. In brief words, the software calcu-
lates the effects of each supplement for every readout, self-renewal or pluripotency, by utilizing the least 
square method. The error of each sample is estimated from the error obtained by the genuine replicates 
performed on the central points of the matrix, condition number 9, done at least in 4 independent exper-
iments. Afterwards, the software is able to generate the relevance of each factor by comparing the ratio 
of the calculated effects and its errors with the bilateral Student’s t-distribution with the proper degree 
of freedom. Then, the p-value is obtained for each parameter of the model. A conservative approach was 
adopted and all parameters with a p-value < 0.1 were considered statistical relevant for the mathematical 
model. Note that a probability normal plot was performed and samples followed a linear straight line, 
therefore, suggesting a normal distribution. No “S” shapes, characteristics from bimodal distributions, 
and also, no breaks in any part of the range analyzed, that could suggest other abnormalities, were 
identified.
Human embryonic stem cell culture. H9 cells were obtained from Human Stem Cell Core Facility, 
UCSD, and tested negative for mycoplasma contamination by PCR. They were cultured in feeder-free 
condition using Matrigel (~100 μg/mL, BD Biosciences) as basement membrane matrix, fed with mTeSR1 
(Stemcell Technologies) or different formulations of medium on daily basis and passaged enzymatically 
weekly.
Reprogramming and iPSC maintenance. The study protocols were approved by IRB/ESCRO 
committee review (IRB#100574ZF). Female human primary fibroblasts were obtained with informed 
consent from subjects and tested negative for mycoplasma contamination by PCR. The fibroblasts were 
reprogrammed and characterized using the method previously described elsewhere17. Upon manual 
isolation from MEFs, iPSCs were grown on Matrigel-coated dish in either iDEAL (see Supplementary 
Table 2 for complete composition) or mTeSR1 (Stemcell Technologies). For media change and single-cell 
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plating experiments, one clone for each line (3 lines in total) was used. For X chromosome inactivation 
experiments, six clones of one line were used. Summary of clones and technical replicates for each 
experiment could be found in Supplementary Table 3. Medium was changed daily. iPSCs were passaged 
semi-enzymatically on weekly basis. Briefly, cells were incubated in calcium- and magnesium-free PBS 
for 5 min and lifted using cell scraper. After partial dissociation by up-and-down pipetting, cells were 
plated onto new Matrigel-coated plate. Note that no removal of differentiated cells was done prior to the 
passaging.
Embryoid body (EB) formation and RNA extraction. 70-90% confluent iPSCs (day 6-7 after pas-
saging) were fed with N2 medium (1X N2 supplement (Life Technologies) in DMEM/F12 (Cellgro)) 
for 2 days. On the next day, iPSCs were treated with calcium- and magnesium-free PBS for 5 min and 
lifted using cell scraper. Next, iPSCs were transferred to one well in 6-well plate in N2 medium supple-
mented with 1% fetal bovine serum (Gemini Bio-Products), and cultured on shaker at 37 °C. Medium 
was replaced every 3 days. After 20 days on the shaker, RNA extraction from EB was performed using 
Trizol® (Life Technologies) according to manufacturer protocol.
Teratoma formation assay. iPSC colonies from 2 confluent 100 mm dishes were harvested after 
treatment with StemPro® Accutase® (Life Techonologies), pelleted, and suspended in 300 μL Matrigel. 
The cells were injected subcutaneously into nude mice; 6 to 8 weeks after injection, teratomas were dis-
sected, fixed overnight in 10% buffered formalin phosphate, and embedded in paraffin. The sections were 
stained with hematoxylin and eosin for further analysis. The protocols were approved by the University 
of California San Diego Institutional Animal Care and Use Committee.
Media change experiments. iPSC derived in either iDEAL or mTeSR1 were passaged 
semi-enzymatically as described above and seeded onto Matrigel-coated 6-well plate at density of 1 × 105 
cells/well . Media change was done on a daily basis from day 1 to 6 for ‘Daily’ condition. For ‘Skip’ con-
dition, feeding was done on a daily basis from day 1 to 4 and omitted on day 5 and 6. On day 7, iPSCs 
were completely dissociated using Stempro® Accutase® (Life technologies) and collected; one half was 
used for cell death analysis and the other for pluripotency analysis.
Cell death analysis. iPSCs collected at day 7 were fixed using cold absolute ethanol overnight at 4 °C. 
After 2 washes with PBS, cells were incubated in staining solution (20 μg/mL of propidium iodide and 
200 μg/mL of RNase in PBS) for 30 min at room temperature. Flow cytometry was done on a FACSCanto™ 
II (BD Biosciences) and analyzed using Flowjo (Tree Star, Inc). Sub-G1 population was used to calculate 
the following parameters; (1) percentage of cell death in ‘Daily’ condition, (2) increase in cell death in 
‘Skip’ condition over corresponding ‘Daily’ condition.
Pluripotency analysis. iPSCs collected were fixed with 4% paraformaldehyde in PBS for 15 min and 
washed with PBS for 3 times, 5 min each. Cells were then permeabilized and blocked with 0.1% triton X 
and 2.5% bovine serum albumin for 30 min and incubated with primary antibodies (mouse anti-OCT4 
from Santa Cruz (cat#SC-5279), 1:250; rabbit anti-NANOG from GeneTex (cat#GTX100863), 1:400) 
for 30 min at 4 °C. After washed with PBS for 3 times, cells were incubated with secondary antibodies 
(Alexa Fluor 488 donkey anti-mouse IgG (cat#A21202), 1:500; Alexa Fluor 555 donkey anti-rabbit IgG 
(cat#A31572), 1:500, from Life Technologies) for 30 min at 4 °C. After washed, flow cytometry was done 
on LSRFortessa (BD Biosciences) and analyzed using FACSDIVA (BD Biosciences). Every sample was 
used for the analysis. For media change experiment, population with dual staining (both OCT4 and 
NANOG positive) was used to calculate the following parameters; (1) percentage of pluripotent cells in 
‘Daily’ condition, (2) reduction in pluripotent cells in ‘Skip’ condition over corresponding ‘Daily’ condi-
tion. For single-cell plating experiment, population with dual staining (OCT4 and NANOG) was used to 
calculate the percentage of cells remaining pluripotent at day 7 after plated as single cells.
Single-cell plating. iPSCs at 80% confluency were completely dissociated after incubation with 
Stempro® Accutase® (Life technologies) for 5 min. Cells were passed through 40 μm cell strainer to ensure 
the singularity (Supplementary Fig. 2), counted using Trypan Blue exclusion assay and then seeded onto 
Matrigel-coated 6-well plate at density of 2 × 105 cells/well (day 0). ROCK inhibitor (10 μM, R&D system) 
was added with the media only on day 0 to improve the survival20. Media were then changed daily. Cells 
were collected at day 1 for survival analysis and at day 7 for pluripotency analysis.
Survival analysis. At 24 hours after single-cell plating, cells were collected, completely dissociated 
using Stempro® Accutase® (Life technologies) and counted using Trypan Blue exclusion assay. Survival 
index was determined by dividing number of live cells collected at day 1 by number of cells seeded on 
day 0 (2 × 105 cells).
Statistical analysis for pluripotency, cell death and survival. Mean ± s.e.m. for each parame-
ters mentioned above were obtained from 3 and 4 independent technical replicates of one clone for 
each of 3 iPSC lines for media change and single-cell plating experiments, respectively. There were no 
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adjustments for multiple comparisons. To statistically compare the means of two unmatched groups 
where normal distribution and similar variance between groups was statistically confirmed, two-sided 
unpaired Student’s t-test was used and significance was defined as P < 0.05.
Immunofluorescence staining. iPSCs were fixed with 4% paraformaldehyde in PBS for 15 min 
and washed with PBS for 3 times, 5 min each. Cells were then permeabilized and blocked with 0.1% 
triton X and 2.5% bovine serum albumin in PBS for 1 hour and incubated in primary antibodies 
overnight at 4 °C (mouse anti-OCT4 from Santa Cruz (cat#SC-5279), 1:250; rabbit anti-LIN28 from 
Abcam (cat#AB46020), 1:500; mouse anti-SSEA4 from Abcam (cat#MC813), 1:200; rabbit anti-NANOG 
from GeneTex (cat#GTX100863), 1:300; goat anti-NANOG from R&D (cat#AF1997), 1:250; rabbit 
anti-H3K27me3 from Millipore (cat#07-449), 1:500); mouse anti-Tra-1-60 from Abcam (cat#AB16288), 
1:500; and anti-Tra-1-81 Alexa647 from BD Biosciences (cat#BDB560124), 1:10). After washed with PBS 
for 3 times, 5 min each, cells were incubated in secondary antibodies if necessary (Alexa Fluor 488 don-
key anti-mouse IgG (cat#A21202), 1:500; Alexa Fluor 555 donkey anti-rabbit IgG (cat#A31572), 1:500; 
Alexa Fluor 488 donkey anti-goat IgG (cat#A11055), 1:500, from Life Technologies) for 1 hour at room 
temperature and nuclei were stained using DAPI (1:5000).
X inactivation (media swap) experiments. iPSCs derived in either iDEAL or mTeSR1 were con-
tinuously cultured in its original medium until passage 6. At passage 7, iPSCs derived in iDEAL were 
split into two culture conditions; one was still fed with iDEAL and the other was fed with mTeSR1 until 
passage 10. The same strategy was applied to iPSCs derived in mTeSR1. Immunofluorescence staining 
against H3K27me3 (described above) was performed in iPSCs at passage 4 and 10 of all conditions. 
Images were obtained using an Olympus Fluoview FV1000 confocal microscope.
Fluorescence in situ hybridization (FISH). iPSCs were grown in 25cm2 tissue culture flask until 
60-70% confluency. FISH for XIST were performed by Molecular Diagnostic Services (San Diego, CA)39.
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